The
persisting autism mystery
From the editors of the Harvard Mental Health
Letter. For subscription information,
click here. (Added: 04/01/2003)
After remaining stable for 20 years, the rate of reported autism has
been rising steadily since 1990 in Europe and America alike. This
devastating brain disorder is characterized by an extremely limited
range of activities and interests and lack of the capacity to
communicate with others, take their perspective, or share their
experience (see Harvard Mental Health Letter, June and July
2001). A recent survey of California children suggests that the
current trend is not due merely to changing diagnostic standards.
Epidemiologists at the Centers for Disease Control and Prevention
(CDC) in Atlanta, using different methods, have confirmed the rise
in autism diagnoses while expressing more doubt about its causes.
Meanwhile, other research has been refuting one of the most popular
and most alarming explanations for the trend.
The number of cases of autism reported to state regional centers
for the treatment of developmental disorders in California nearly
quadrupled between 1987 and 1998, while the state's population was
rising by only 20%. Diagnoses rose 16% between 1997 and 1998 alone.
The state legislature commissioned epidemiologists from the
University of California at Davis to study the problem.
Using clinic records, a diagnostic interview, and a questionnaire
answered by parents, the researchers compiled information on nearly
700 children with developmental disorders in two age groups, one
born in the mid-1980s and the other in the mid-1990s. About half of
the children were diagnosed as autistic and half as retarded but not
autistic.
The researchers did not find that parents and professionals had
begun to use the label of autism more freely. The autistic symptoms
of older and younger children were similar. About 20% of autistic
children were misclassified as retarded but not autistic. That
proportion was no higher in the older children than it was in the
younger children, so misclassification could not explain the change.
The upsurge in autism seemed to be real.
The CDC researchers surveyed children ages 310 in five counties
of metropolitan Atlanta in 1996. They identified autism not only by
referrals to clinics, as in the California study, but also by
seeking other sources including children's hospitals, private
physicians, and above all 40% of the cases school records.
They found nearly 1,000 children with autistic spectrum
disorders, which included not only classic autism (two-thirds of the
cases) but also milder related syndromes such as pervasive
developmental disorder and Asperger's syndrome (normal intelligence
and adequate language along with more or less severe autistic social
and emotional deficiencies). That represented a prevalence of 34
cases in every 10,000 children similar to the result of the
California study and much higher than the rate indicated by earlier
research. In studies conducted before 1985, for example, the rate of
autism was about seven times lower, 5 per 10,000. Three American
surveys in the early 1990s found similarly low rates.
But some skepticism is expressed in the CDC report and especially
by an editorial commentator in the January 2003 issue of the
Journal of the American Medical Association, where the
results were published. The commentator argues that reports of
autism could be rising because the public and professionals are
becoming more aware of its existence and sensitive to its symptoms.
More services are available, too. Federal law now requires states to
provide special education programs for autistic children at public
expense, and there is new evidence that some autistic symptoms
respond to intensive behavioral treatment at an early age.
The California researchers acknowledge that the ability to notice
and report signs of autism might have been improving. In California,
among children born in the 1980s, 50% of autistic children were also
diagnosed as retarded, compared with a much lower 22% among children
born in the 1990s. Parents might have become more sensitive to
autism in children who were not retarded.
Vaccination controversy
A popular suspect in autism is the measles-mumps-rubella (MMR)
vaccine, which came into widespread use around 1990. Children are
given the vaccine, which contains viruses that could theoretically
infect the brain, at about 15 months of age. Among parents of the
younger children in the California survey, more than 20% had avoided
or delayed immunizing one of their children because of this fear.
To the relief of public health officials and parents concerned
about contagious diseases, it is becoming increasingly clear that
immunization is not the source of the problem. In the
California study, developmental regression reversal of previously
normal intellectual and emotional growth, which should be seen if
the vaccination were causing harm did not occur more often in
children born in the 1990s than in those born in the 1980s.
And northern European studies have been providing further
evidence that vaccines are innocent. A Danish survey included all of
the 500,000 children born in the country between 1991 and 1998.
After adjustments for age, sex, birth weight, and the mother's
education and social class, children who received the MMR vaccine
about 80% of the total had a slightly lower rate of autistic
disorders than those who were not vaccinated. And autistic symptoms
were no more likely to appear shortly after vaccination than at any
other time.
A survey of more than 500,000 Finnish children who received the
MMR vaccine in the early 1980s confirms the Danish results. The
number of children brought to hospitals for observation because of
newly recognized autistic symptoms did not rise in the three months
after vaccination.
The concern about vaccines results partly from the use of methyl
mercury (also called thiomersal or thimerosal), a preservative that
contains a small amount of the toxic heavy metal. It was removed
from vaccines administered in the United States in 1999, but it is
still used in other countries and regarded as safe by the World
Health Organization.
A recent American study indicates that blood levels of mercury
did not become unusually high in children who received
thiomersal-containing vaccines for diphtheria, tetanus, whooping
cough, hepatitis B, and influenza at 2, 4, and 6 months of age. They
were compared with controls who took the same vaccines packaged
without the preservative. Mercury levels were the same in both
groups and well below the amount considered dangerous to health. The
mercury in thiomersal also passed out of the body much faster than
expected a half-life of about one week rather than seven weeks
so it did not build up with repeated vaccinations.
These results should reassure parents of newborns facing
vaccination. For now, no other satisfying environmental explanation
for the rise in autism is evident. The University of California at
Davis is establishing a research center to look for possible effects
of pesticides, polychlorinated biphenyls (PCBs), heavy metals, and
other contaminants. The CDC is tracking autism levels in several
states using the same methods employed in the Atlanta research.
Further study should tell us whether the rise in rates is in the
eyes of the beholders or represents a true increase in the number of
autism cases.
References
Byrd R, et al. "Report to the Legislature on
the Principal Findings from The Epidemiology of
Autism in California: A Comprehensive Pilot Study"
(2002).
http://mindinstitute.ucdmc.ucdavis.edu
/news/report.htm
Department of Developmental Services, State of
California. "Changes in the Population of Persons
with Autism and Pervasive Developmental Disorders in
California's Developmental Services System: 1987 through
1998. A Report to the Legislature, March 1, 1999."
www.dds.ca.gov/autism/pdf
/autism_report_1999.pdf
Fombonne E. "The Prevalence of Autism,"
Journal of the American Medical Association
(January 1, 2003): Vol. 289, No. 1, pp. 8789.
Pichichero ME, et al. "Mercury Concentrations
and Metabolism in Infants Receiving Vaccines Containing
Thiomersal: A Descriptive Study," Lancet
(November 30, 2002): Vol. 360, No. 9347, pp. 173741.
Yeargin-Allsop M, et al. "Prevalence of Autism
in a U.S. Metropolitan Area," Journal of the American
Medical Association (January 1, 2003): Vol. 289, No.
1, pp. 4955. |
|